Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen lysinate versus ibuprofen in children with inflammatory or postoperative pain
2019-000647-27Phase 2Terminated
- Sponsor
- Dicofarm
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ibuprofen in postoperative pain and Inflammatory pain is not a disease; it is a symptom or type of pain associated with various inflammatory conditions (2 arms), sponsored by Dicofarm. Primary endpoint: Analgesic efficacy. Started Oct 2020; status: terminated.
02
Drugs
ibuprofen
03
Conditions
postoperative painInflammatory pain is not a disease; it is a symptom or type of pain associated with various inflammatory conditions.
Beyond the preview
Go deeper on 2019-000647-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000647-27.